Thailand said it's okay to use some strong medicines like opium and special mushrooms for helping people feel better or learn new things. This is a big change from before when they were not allowed. Read from source...

- The article title is misleading and sensationalized, implying that opium and magic mushrooms are novel or exotic substances for medical and research purposes, when in fact they have a long history of use in various cultures and traditions. A more accurate title could be "Thailand Legalizes Opium And Magic Mushrooms For Medical And Research Purposes".
- The article body repeats the term "landmark shift" without providing any context or evidence for its significance or impact. It also uses vague terms like "drug policy" and "sanctioned" without defining them or explaining how they differ from previous regulations or practices. A more informative article would provide some historical and comparative perspective on Thailand's drug policies and their alignment with international standards and norms.
- The article cites El Planteo as a source, but does not disclose the authorship, affiliation, or credibility of this publication. It also does not link to the original article or provide any quotes or excerpts from it. A more transparent and reliable article would verify the information from multiple sources and indicate the potential bias or conflict of interest of its own authors or publishers.
- The article ends with a quote from an unnamed official, who presumably supports the decision to approve opium and magic mushrooms for medical and research purposes. However, the quote does not provide any specific details or reasons for this approval, nor does it address any potential challenges or risks associated with it. A more persuasive article would include a balanced representation of different opinions and perspectives on this issue, as well as some evidence-based arguments or data to support its claims.

Positive

Summary: The article reports on a significant change in Thailand's drug policy, as the country has officially approved the medical and research use of opium and psilocybin mushrooms. This decision is expected to have a major impact on the future of psychedelic-assisted therapies and medicines in the region and beyond.

1. Opium-based pharmaceuticals and derivatives: There is a significant potential for growth in this sector, as opium has been proven to have various medicinal properties, such as pain relief, sedation, and analgesia. Additionally, the global opioid market size was valued at $52.47 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028. However, investors should be aware of the legal and regulatory challenges associated with opium-based products, as well as the potential for addiction and abuse.